Cosmo Bio Company,Limited (TYO:3386)

Japan · Delayed Price · Currency is JPY

1,233.00

0.00 (0.00%)

Aug 19, 2026, 1:09 PM JST

Cosmo Bio Company,Limited Financials Overview

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	11,278	10,766	10,037	9,340	9,553	9,231
Revenue Growth	9.39%	7.26%	7.46%	-2.23%	3.49%	14.08%
Gross Profit	3,877	3,702	3,329	3,250	3,441	3,659
Operating Income	348	343	319	521	817	1,050
Net Income	364	337	262	442	517	737
Earnings Per Share	64.10	59.26	45.05	75.83	89.06	126.88
EPS Growth	44.97%	31.54%	-40.59%	-14.85%	-29.81%	11.59%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	4,068	2,946	2,693	3,025	3,036	3,555
Total Debt	20	20	20	20	20	20
Net Cash (Debt)	4,048	2,926	2,673	3,005	3,016	3,535
Net Cash Growth	27.62%	9.46%	-11.05%	-0.36%	-14.68%	9.14%
Net Cash Per Share	712.90	514.49	459.61	515.57	519.52	608.56

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	619	595	241	736	284	648
Capital Expenditures	-311	-229	-216	-67	-55	-31
Free Cash Flow	308	366	25	669	229	617
Free Cash Flow Growth	-28.37%	1364.00%	-96.26%	192.14%	-62.89%	-19.56%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	34.38%	34.39%	33.17%	34.80%	36.02%	39.64%
Operating Margin	3.09%	3.19%	3.18%	5.58%	8.55%	11.38%
Pretax Margin	4.81%	4.68%	3.67%	6.98%	8.27%	11.89%
Profit Margin	3.23%	3.13%	2.61%	4.73%	5.41%	7.98%
FCF Margin	2.73%	3.40%	0.25%	7.16%	2.40%	6.68%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	50.000	50.000	50.000	30.000	36.000	36.000
Dividend Per Share Growth	0%	0%	66.67%	-16.67%	0%	5.88%
Dividend Yield	4.06%	3.91%	4.91%	3.39%	4.09%	3.68%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	19.23	21.96	23.80	12.98	11.37	9.13
P/FCF Ratio	22.81	20.22	249.44	8.57	25.67	10.91
PS Ratio	0.62	0.69	0.62	0.61	0.62	0.73